MedPath

Aramis Biosciences, Inc.

Aramis Biosciences, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2018-01-01
Employees
1
Market Cap
-
Website
http://www.aramisbio.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease

Phase 2
Completed
Conditions
Dry Eye Disease
Interventions
Drug: A197 Ophthalmic Solution
Drug: Active Comparator
Drug: A197 Vehicle Control
First Posted Date
2022-02-14
Last Posted Date
2023-05-16
Lead Sponsor
Aramis Biosciences, Inc.
Target Recruit Count
207
Registration Number
NCT05238597
Locations
🇺🇸

Aramis Site 113, Birmingham, Alabama, United States

🇺🇸

Aramis Site 121, Garden Grove, California, United States

🇺🇸

Aramis Site 120, Glendale, California, United States

and more 21 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.